NCT02320357View on ClinicalTrials.gov

Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 19, 2015

Primary Completion Date

September 11, 2017

Study Completion Date

September 11, 2017

Conditions

Systemic Lupus Erythematous

Interventions

DRUG

Treatment by clopidogrel

Peripheral blood will be obtained during the study

Trial Locations (3)

33075

Service de Médecine Interne et maladies Infectieuses - Hôpital Saint-André, Bordeaux

87000

Service de Médecine Interne, Limoges

31 000

Service de Médecine Interne et Immunopathologie, Toulouse

All Listed Sponsors

collaborator

Ministry for Health and Solidarity, France

OTHER_GOV

lead

University Hospital, Bordeaux

OTHER

NCT02320357 - Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous | Biotech Hunter | Biotech Hunter